Mapping of the .beta.2-adrenoceptor on Chang liver cells. Differences between high- and low-affinity receptor states

Journal of Medicinal Chemistry
1988.0

Abstract

Receptor mapping procedures based on the methodology of Crippen are used to study the beta 2-adrenergic receptor system in intact Chang liver cells. In cases of agonists, the presence of both a low- and high-affinity receptor state is assumed, whereas antagonists bind to the low-affinity state only. The high-affinity state is considered to contain the "functional" binding site responsible for formation of the second messenger (cAMP), whereas the low-affinity state is assumed to be the "true" (physiological) low-affinity state. Both receptor states are taken into account in the receptor mapping process. Characterization of the high- and low-affinity states made it possible to identify features that make a state an antagonist or agonist. The receptor model found for the low-affinity state of the beta-adrenergic receptor present in an intact cell system is compared to the low-affinity state previously obtained for this receptor present on a membrane preparation of the bovine skeletal muscle in the presence of high amounts of Gpp(NH)p guanosine 5'-(beta, gamma-imidotriphosphate). Remarkable differences are found between the two receptor models. The tentative conclusion is drawn that these differences in low-affinity states most probably are artificial and are caused by the different pharmacological properties (e.g., intrinsic activity) of the labeled ligands used in displacement experiments for determining the affinities of the drugs.

Knowledge Graph

Similar Paper

Mapping of the .beta.2-adrenoceptor on Chang liver cells. Differences between high- and low-affinity receptor states
Journal of Medicinal Chemistry 1988.0
Design and synthesis of naltrexone-derived affinity labels with nonequilibrium opioid agonist and antagonist activities. Evidence for the existence of different .mu. receptor subtypes in different tissues
Journal of Medicinal Chemistry 1984.0
Computer-aided mapping of the .beta.-adrenoceptor I: Explanation for effect of para substitution on blocking activity at the .beta.-1-adrenoceptor
Journal of Medicinal Chemistry 1992.0
Mapping the turkey erythrocyte .beta.-receptor: a distance geometry approach
Journal of Medicinal Chemistry 1986.0
Conformational effects on the activity of drugs. 13. A revision of previously proposed models for the activation of .alpha.- and .beta.-adrenergic receptors
Journal of Medicinal Chemistry 1992.0
Pharmacology of the agonist binding sites of rat neuronal nicotinic receptor subtypes expressed in HEK 293 cells
Bioorganic & Medicinal Chemistry Letters 2004.0
Discovery of 7-hydroxyaporphines as conformationally restricted ligands for beta-1 and beta-2 adrenergic receptors
MedChemComm 2018.0
Structural basis of the selectivity of the β2-adrenergic receptor for fluorinated catecholamines
Bioorganic & Medicinal Chemistry 2009.0
Biophysical Mapping of the Adenosine A<sub>2A</sub> Receptor
Journal of Medicinal Chemistry 2011.0
Quantitative evaluation of the .beta.2-adrenoceptor affinity of phenoxypropanolamines and phenylethanolamines
Journal of Medicinal Chemistry 1985.0